The Journal of allergy and clinical immunology · 2024
Mast cell activation syndrome: Current understanding and research needs.
СтатьяОбзорПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Castells Mariana, Giannetti Matthew P, Hamilton Matthew J, Novak Peter, Pozdnyakova Olga, Nicoloro-SantaBarbara Jennifer, Jennings Susan V, Francomano Clair, Kim Brian, Glover Sarah C, Galli Stephen J, Maitland Anne, White Andrew, Abonia J Pablo, Slee Valerie, Valent Peter, Butterfield Joseph H, Carter Melody, Metcalfe Dean D, Akin Cem, Lyons Jonathan J, Togias Alkis, Wheatley Lisa, Milner Joshua D
Аннотация
Mast cell activation syndrome (MCAS) is a term applied to several clinical entities that have gained increased attention from patients and medical providers. Although several descriptive publications about MCAS exist, there are many gaps in knowledge, resulting in confusion about this clinical syndrome. Whether MCAS is a primary syndrome or exists as a constellation of symptoms in the context of known inflammatory, allergic, or clonal disorders associated with systemic mast cell activation is not well understood. More importantly, the underlying mechanisms and pathways that lead to mast cell activation in MCAS patients remain to be elucidated. Here we summarize the known literature, identify gaps in knowledge, and highlight research needs. Covered topics include contextualization of MCAS and MCAS-like endotypes and related diagnostic evaluations; mechanistic research; management of typical and refractory symptoms; and MCAS-specific education for patients and health care providers.